DAVID BENNION: Open Payments
NPI 1255435244 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 96 payments from 16 companies in 2025. Trend: 2023 $1,349 · 2024 $1,977 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $358 |
| PFIZER INC. | 23 | $218 |
| Axsome Therapeutics, Inc. | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| Astellas Pharma US Inc | 7 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| Amgen Inc. | 2 | $29 |
| Edwards Lifesciences Corporation | 1 | $24 |
Products named: NURTEC ODT, VRAYLAR, Veozah, AIRSUPRA, UBRELVY, LEQVIO, QULIPTA, Auvelity.
Industry payments across UT — which companies pay providers there.
